ArticleScientific reports2025

Establishment of novel cholangiocarcinoma cell lines with ARID1A deficiency and preclinical validation of synthetic lethality therapies.

Sunisa Prasopporn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.